发明名称 |
(1S, 4R, 6S, 14S, 18R)-4-FLUORO-1,3-DIHYDRO-ISOINDOLE-2-CARBOXYLIC ACID 14-TERT-BUTOXYCARBONYLAMINO-4-CYCLOPROPANESULFONYLAMINOCARBONYL-2,15-DIOXO-3,16-DIAZATRICYCLONONADEC-7-EN-18-YL ESTER AND ITS USE FOR THE MANUFACTURE OF AN ANTI-HCV INFECTION MEDICAMENT |
摘要 |
The present invention provides compounds of the general formulas I-IX, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The present invention further provides treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition. |
申请公布号 |
IL174704(A) |
申请公布日期 |
2012.12.31 |
申请号 |
IL20060174704 |
申请日期 |
2006.03.30 |
申请人 |
F. HOFFMANN-LA ROCHE LTD;F. HOFFMANN-LA ROCHE LTD.;INTERMUNE, INC.;ARRAY BIOPHARMA, INC;F. HOFFMANN-LA ROCHE LTD;F. HOFFMANN-LA ROCHE INC. |
发明人 |
|
分类号 |
A61K;A61K38/00;C07D487/04;C08H1/00 |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|